|
National Stock Number(NSN): 6505-01-153-3811 (6505011533811, 011533811)
| NIIN: |
01-153-3811 |
Item Name: |
THEOPHYLLINE EXTENDED-RELEASE CAPSULES |
INC: |
42774
|
| FSC: |
6505
|
Assignment Date: |
May-15-1983 |
CRIT: |
N |
IIG: |
42774 |
| ISC: |
2 |
Date Standardized: |
Oct-24-1988 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Jun-01-1996 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00067-1354-68 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
5 |
9 |
4 |
KX |
|
|
|
|
|
|
|
NDC00075-1354-00 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
SLO-PHYLLIN 60 GYROCAPS |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
Z |
M |
U |
1 |
A |
$10.07 |
BT |
|
C2201X- |
Jun-01-1994 |
H |
| DF |
S9M |
Y |
|
M |
U |
1 |
F |
$10.07 |
BT |
|
------- |
Jun-01-1995 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$10.07 |
BT |
|
9L----- |
Jun-01-1994 |
H |
| DS |
S9M |
Y |
|
M |
U |
1 |
D |
$10.07 |
BT |
|
------- |
Jun-01-1994 |
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
60.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
2.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.105 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
12 |
| FEAT |
SPECIAL FEATURES |
ANHYDROUS |
| SUCB |
UNIT OF ISSUE CUBE |
0.014 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.18 POUNDS |
| THPE |
THERAPEUTIC EQUIVALENT |
RORER PHARMACEUTICAL CORPORATION |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| FSKX |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| N9LM |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
Replacement & Obsolete Information
| Obsolete NIIN Information |
|